Home Healthcare Pharmaceuticals Hydroxyzine Market

Hydroxyzine Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Capsules, Injection, Syrup), By Indication Type (Histamine-Mediated Pruritus, Urticaria, Atopic Contact Dermatoses) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Hydroxyzine Market, By Dosage Form  2022-2034 (USD MILLION/ Units)
    1. Tablets
    2. Capsules
    3. Injection
    4. Syrup
  2. Hydroxyzine Market, By Indication Type  2022-2034 (USD MILLION/ Units)
    1. Histamine-Mediated Pruritus
    2. Urticaria
    3. Atopic Contact Dermatoses
  3. Regional Hydroxyzine Market
    1. North America
      1. North America Hydroxyzine Market By Dosage Form  2022-2034 (USD MILLION/ Units)
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
      2. North America Hydroxyzine Market By Indication Type  2022-2034 (USD MILLION/ Units)
        1. Histamine-Mediated Pruritus
        2. Urticaria
        3. Atopic Contact Dermatoses
      3. U.S.
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      4. Canada
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
    2. Europe
      1. Europe Hydroxyzine Market By Dosage Form  2022-2034 (USD MILLION/ Units)
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
      2. Europe Hydroxyzine Market By Indication Type  2022-2034 (USD MILLION/ Units)
        1. Histamine-Mediated Pruritus
        2. Urticaria
        3. Atopic Contact Dermatoses
      3. U.K.
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      4. Germany
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      5. France
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      6. Spain
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      7. Italy
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      8. Russia
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      9. Nordic
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      10. Benelux
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      11. Rest of Europe
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
    3. APAC
      1. APAC Hydroxyzine Market By Dosage Form  2022-2034 (USD MILLION/ Units)
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
      2. APAC Hydroxyzine Market By Indication Type  2022-2034 (USD MILLION/ Units)
        1. Histamine-Mediated Pruritus
        2. Urticaria
        3. Atopic Contact Dermatoses
      3. China
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      4. Korea
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      5. Japan
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      6. India
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      7. Australia
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      8. Singapore
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      9. Taiwan
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      10. South East Asia
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      11. Rest of Asia-Pacific
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
    4. Middle East and Africa
      1. Middle East and Africa Hydroxyzine Market By Dosage Form  2022-2034 (USD MILLION/ Units)
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
      2. Middle East and Africa Hydroxyzine Market By Indication Type  2022-2034 (USD MILLION/ Units)
        1. Histamine-Mediated Pruritus
        2. Urticaria
        3. Atopic Contact Dermatoses
      3. UAE
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      4. Turkey
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      5. Saudi Arabia
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      6. South Africa
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      7. Egypt
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      8. Nigeria
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      9. Rest of MEA
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
    5. LATAM
      1. LATAM Hydroxyzine Market By Dosage Form  2022-2034 (USD MILLION/ Units)
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
      2. LATAM Hydroxyzine Market By Indication Type  2022-2034 (USD MILLION/ Units)
        1. Histamine-Mediated Pruritus
        2. Urticaria
        3. Atopic Contact Dermatoses
      3. Brazil
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      4. Mexico
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      5. Argentina
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      6. Chile
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      7. Colombia
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
      8. Rest of LATAM
        1. Tablets
        2. Capsules
        3. Injection
        4. Syrup
        5. Histamine-Mediated Pruritus
        6. Urticaria
        7. Atopic Contact Dermatoses
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.